Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Osawa S, Funamoto S, Nobuhara M, Wada-Kakuda S, Shimojo M, Yagishita S, Ihara Y. Phosphoinositides suppress gamma-secretase in both the detergent-soluble and -insoluble states. J Biol Chem. 2008 Jul 11;283(28):19283-92. PubMed Abstract

Comments on Paper and Primary News
  Comment by:  Gilbert Di Paolo, Min Suk Kang, Tae-Wan Kim, Laura Beth McIntire
Submitted 5 June 2008  |  Permalink Posted 5 June 2008

Comment by Tae-Wan Kim, Laura Beth McIntire, Min Suk Kang, and Gilbert Di Paolo
Our previous study reported that the levels of secreted Aβ42 were found to inversely correlate with the levels of phosphatidylinositol-4,5-bisphosphate, also known as PI(4,5)P2 (see Landman et al., 2006). For instance, Aβ42 production is decreased in cells with elevated PI(4,5)P2 levels (e.g., cells treated with edelfosine, a phospholipase C inhibitor), while Aβ42 levels are increased in cells with lower PI(4,5)P2 levels (e.g., cells overexpressing synaptojanin 1, a PI(4,5)P2 5-phosphatase).

This elegant biochemical study by Yasuo Ihara and colleagues provides further insight into how alterations in the lipid composition of the membrane could influence the activity of the membrane-embedded γ-secretase complex. The authors found that PI(4,5)P2 directly influences the activity of γ-secretase using cell-free assays. PI(4,5)P2 was shown to competitively inhibit γ-secretase activity by suppressing the association of the γ-secretase complex with the substrate. Thus, this study provides the...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
Antibodies used in this study are:
Western blotting for Aβ quantification, mouse monoclonal anti-Amyloidβ (6E10) (Signet Covance); mouse monoclonal anti-Amyloidβ 1-40 BA27 (highly specific for the Aβ40 carboxyl terminus) (Dr. A. Asami, Takeda Chemical Industries). Aβ on the membrane was visualized by an ECL system (GE healthcare) using well-characterized antibodies, mouse monoclonal anti-Aβ N-terminal (82E1) (IBL Japan) and mouse monoclonal anti-Amyloidβ (BC05) raised against Aβ35-43, specific for the Aβ42 carboxyl terminus, but crossreactive with CTFs and full-length APP, (Dr. A. Asami, Takeda Chemical Industries).
γ-Secretase-dependent S3 cleavage was visualized by detecting shortened Notch intracellular domain fused with FLAG tag (sNICD-FLAG) with mouse monoclonal anti-FLAG® (M2) (Sigma Aldrich); γ-Secretase complex was immunoprecipitated with rabbit anti-nicastrin (Sigma).
Presenilin 1 CTF, Aph-1 and Pen-2 were detected with anti-presenilin 1 CTF antiserum (a gift from Dr. Iwatsubo, University of Tokyo), anti-Aph1 polyclonal antibody (Covance) and rabbit anti-Pen-2 polyclonal antibody (Shimojo, et al.)

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad